Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Clinical Chemistry|January 4, 2024
Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic CancerRicardo A León-Letelier, Rongzhang Dou, Jody Vykoukal, et al.
Cancers|March 6, 2021
A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian CancerJohannes F Fahrmann, Ehsan Irajizad, Makoto Kobayashi, et al.
Cancers|September 9, 2022
Contributions of Circulating microRNAs for Early Detection of Lung CancerJody Vykoukal, Johannes F Fahrmann, Nikul Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2013
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancerJennifer B Dennison, Jennifer R Molina, Shreya Mitra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 2, 2020
Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary NodulesEdwin J Ostrin, Leonidas E Bantis, David O Wilson, et al.
Radiology. Artificial Intelligence|August 5, 2021
A Deep Learning Approach to Re-create Raw Full-Field Digital Mammograms for Breast Density and Texture AnalysisHai Shu, Tingyu Chiang, Peng Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk AssessmentJohannes F Fahrmann, Tracey Marsh, Ehsan Irajizad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2022
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic MassesEhsan Irajizad, Chae Y Han, Joseph Celestino, et al.
Cell Reports. Medicine|December 17, 2025
Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapyYihui Chen, Rongzhang Dou, Monica J Hong, et al.
Cancer Research|June 25, 2017
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling PathwaySatyendra C Tripathi, Johannes F Fahrmann, Muge Celiktas, et al.
Pageof 8